top
Search terms
Results 1 - 5 of 5 - ordered by :
Epeuropace

Healthcare personnel resource burden related to in-clinic follow-up of cardiovascular implantable electronic devices: a European Heart Rhythm Association and Eucomed joint survey Abstract Aims A ...

Europace, CLINICAL RESEARCH, Giuseppe Boriani, Angelo Auricchio, Catherine Klersy, Paulus Kirchhof, Josep Brugada, John Morgan, Panos Vardas

Date : 01/08/2011 Item size : 203920 bytes
Epeuropace

[...]systolic stress and strain as well as external work are reduced in early-activated regions and increased in late-activated regions.7 The opposing length changes during systole are, most likely, ...

Europace, Review, Angelo Auricchio, Frits W. Prinzen

Date : 01/07/2008
Epeuropace

Abstract Aims Several factors can influence the extent of left ventricular (LV) reverse remodelling after cardiac resynchronization therapy (CRT) in patients with heart failure (HF). Methods and ...

Europace, CLINICAL RESEARCH, Natalia Pezzali, Antonio Curnis, Claudia Specchia, Valentina Carubelli, Loredana Covolo, Francesco Donato, Angelo Auricchio, François Regoli, Marco Metra

Date : 01/10/2013
Epeuropace

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management Biological Therapy (2011) - Daiichi Sankyo : ...

Europace, EHRA/HRS Consensus Statement, Task Force Chairs, Jean-Claude Daubert, Leslie Saxon, Philip B. Adamson, Angelo Auricchio, Ronald D. Berger, John F. Beshai, Ole Breithard, Michele Brignole, ...

Date : 01/09/2012
Epeuropace

First-in-man implantation of leadless ultrasound-based cardiac stimulation pacing system: novel endocardial left ventricular resynchronization therapy in heart failure patients Methods and results ...

Europace, Pacing and resynchronization therapy, Angelo Auricchio, Peter-Paul Delnoy, François Regoli, Martin Seifert, Thanasie Markou, Christian Butter, for the collaborative study group

Date : 01/08/2013